Brandywine plans March groundbreaking for first new high-rise at West Philly’s Schuylkill Yards site
Brandywine Realty Trust plans to begin construction of the first new building at its Schuylkill Yards redevelopment site in March after securing a partner to help finance the West Philadelphia proj
Alley ‘alive’ with art planned for West Philly’s Schuylkill Yards
Alley ‘alive’ with art planned for 3151 Market at Schuylkill Yards
Brandywine CEO Jerry Sweeney sees signs of a big year for owners of high-end commercial real estate (Video)
Brandywine’s CEO Jerry Sweeney joined the Philadelphia Business Journal to discuss the immense opportunities presented to the commercial real estate industry in 2021.
Design of Brandywine's proposed $300M Schuylkill Yards life sciences building takes shape
Our architect for 3151 Market sat down with the Philadelphia Business Journal to discuss design inspiration and differentiators for our new Life Science tower at Schuylkill Yards.
Want a Nice Dinner Out? Your Hotel Room Awaits
Great piece by The New York Times highlighting AKA University City’s partnership with Walnut Street Café to serve elegant prix fixe meals out of hotel suites in FMC Tower at Cira
A Philosophy of West Philadelphia’s Future
Two major construction projects underway this year in West Philadelphia cap a decade of building that has brought over a million square feet of new housing, retail and offices to
Restaurants Are Setting Up Shop in Empty Hotel Suites
Philadelphia’s Walnut Street Cafe has created individual dining experiences in the AKA University City hotel, located 23 floors above the restaurant in the same mixed-use space.
Spotlight On: Jerry Sweeney, President & CEO, Brandywine Realty Trust
Philadelphia’s commercial real estate landscape is morphing toward designs that accommodate post-COVID-friendly environments.
How Philly’s Bioscience Sector Is Driving the City’s Next Big Real Estate Boom
More than a million square feet of lab space are under construction to house the region’s leading life sciences companies and biotech entrepreneurs.